Table I.
Clinical features of systemic sclerosis patients with flow mediated dilation.
| Patient characteristics (n=70) | Total number or mean |
|---|---|
| Limited cutaneous SSc | 49 |
| Diffuse cutaneous SSc | 21 |
| Female | 61 |
| Male | 9 |
| White | 58 |
| Hispanic | S |
| Other race | 4 |
| Systolic blood pressure (mmHg) | 114.6 ± 15 |
| Systolic blood pressure (mmHg) | 70 ± 9 |
| Mean arterial pressure (mmHg) | 85 ± 9 |
| Heart rate (beats/min) | 76 ± 1 |
| Duration of SSc at first FMD visit | 10 ± 9.8 |
| (years) | |
| Smoking | |
| Never | 59 |
| Former | 8 |
| Current | 3 |
| Age | 55.4 ± 11.8 |
| Calcium channel blocker | 68 |
| Ace inhibitor | 1 |
| Angiotensin receptor blocker | 2 |
| Prostacyclin analog | 1 |
| Endothelin receptor agonist | 0 |
| Phosphodiesterase 5 inhibitor | 1 |
| Anti-centromere | 58 |
| Anti-topoi somerase | 9 |
| Anti-RNA polymerase III | 3 |
| Anti-Th/To | 1 |